World Journal of Oncology, ISSN 1920-4531 print, 1920-454X online, Open Access
Article copyright, the authors; Journal compilation copyright, World J Oncol and Elmer Press Inc
Journal website http://www.wjon.org

Original Article

Volume 2, Number 5, October 2011, pages 232-237


Circulating Levels of Agouti-Related Peptide in Endometrial Cancer Survivors

Tables

Table 1. Baseline Characteristics of the Study Subjects
 
Baseline characteristicsCasesControlsp-value
Values given as mean ± SD, p = differences between the cases and controls analysed using Kruskal-Wallis test and Fisher’s exact test
Total number5393
  Menopausal status
  Premenopausal-45 (48%)-
  Postmenopausal53 (100%)48 (52%)0.008
Age (yr)63.2 ± 10.547.1 ± 12.0≤0.0001
  Age at diagnoses (yr)56.6 ± 10.4--
  Age at menarche13.3 ± 1.412.9 ± 1.6NS
  Age at menopause50 ± 5.347.6 ± 5.40.006
BMI [kg.m-2]32.0 ± 636.1 ± 11.80.06
Parity1.8 ± 1.11.4 ± 1NS
History of spontaneous miscarriage9 (17%)18 (19%)NS
Endometrium / myometrium index (EMI)18 ± 9.2 / 40.7 ± 10.1--
Grading1.7 ± 0.8--
Length of disease-free period6.5 ± 4.6--
Self reported diabetes (%)34.0%10.8%0.005
Plasma AgRP levels (pg/ml)
  All women94.7 ± 29.581.5 ± 22.20.002
  Non-obese (BMI < 30 kg/m2)100.5 ± 21.1288.1 ± 24.40.008
  Obese (BMI ≥ 30 kg/m2)91.5 ± 33.177.4 ± 19.80.03

 

Table 2. Plasma AgRP Values According to the Parity
 
Parity012≥ 3p
Values given as mean ± SD, p = differences between the cases and controls analysed using Kruskal-Wallis test and Fisher’s exact test
Cases93.4 ± 30.493.6 ± 36.598 ± 30.489.6 ± 210.96
Controls84.3 ± 15.180.8 ± 29.779.2 ± 21.186.2 ± 27.90.39